南亚2型糖尿病的临床管理
本文为Lancet Diabetes Endocrinol系列综述,聚焦南亚(孟加拉国、不丹、印度、尼泊尔、巴基斯坦、斯里兰卡)2型糖尿病负担与临床管理挑战。文章指出南亚患者发病更年轻、血糖更高,并伴更多血脂异常、肾病和心血管病;强调个体化治疗、从诊断即积极管理危险因素、强化初级保健与转诊体系。
要点
- 南亚2型糖尿病患者发病更年轻,血糖更高,血脂异常、肾病和心血管病更突出。
- 治疗需基于生活方式、表型、环境、社会、文化和经济因素个体化。
- 从诊断起积极管理危险因素,基本治疗包括二甲双胍、低成本他汀和降压药。
核心结论
- 南亚2型糖尿病需个体化治疗,从诊断即积极管理危险因素以减少微血管和大血管并发症。
- 强化初级保健模式、改善转诊衔接和实施康复服务对慢性并发症患者重要。
- 提升医生技能、培训非医师卫生工作者及制定和更新国家临床管理指南对改善区域糖尿病管理至关重要。
研究设计与样本
- 本文为Lancet Diabetes Endocrinol系列综述,描述南亚2型糖尿病负担并讨论改善临床护理的途径。
- 南亚地区定义为孟加拉国、不丹、印度、尼泊尔、巴基斯坦和斯里兰卡。
主要发现
- 与其他族群相比,南亚2型糖尿病患者发病更年轻,并表现为更高血糖、血脂异常、肾病和心血管病。
- 影响治疗的具体问题包括疾病意识差、诊断延迟、治疗不足、使用无效且常有害的替代药物、频繁不依从生活方式建议和药物治疗。
- 年轻发病、诊断延迟和管理不足导致严重并发症早发和过早死亡。
关键数值与推荐
- 从诊断起积极管理危险因素以降低微血管和大血管并发症风险。
- 关注提供基本治疗(如二甲双胍、低成本他汀和降压药)及其他干预如戒烟。
临床怎么用
- 根据多样异质的生活方式、表型、环境、社会、文化和经济因素个体化治疗。
- 强化初级保健模式、改善转诊衔接并实施康复服务以护理慢性并发症患者。
- 提升医生技能、向非医师卫生工作者提供相关培训,并制定和定期更新国家临床管理指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Compared with other ethnic groups, south Asian people with type 2 diabetes tend to develop the disease at a younger age and manifest with higher glycaemia, dyslipidaemia, nephropathy, and cardiovascular diseases. Additionally, specific issues that can affect treatment of type 2 diabetes in south Asia include poor awareness of the disease, delay in diagnosis, inadequate treatment, the use of ineffective and often harmful alternative medicines, and frequent non-compliance with lifestyle recommendations and drug treatment. Disease development at younger ages, delayed diagnosis, and inadequate management result in early development of severe complications and premature mortality. In this Series paper, we describe the challenges associated with the increasing burden of type 2 diabetes in south Asia and discuss ways to improve clinical care of people with the disorder in the region (defined to include Bangladesh, Bhutan, India, Nepal, Pakistan, and Sri Lanka). Treatment of diabetes in south Asia needs to be individualised on the basis of diverse and heterogeneous lifestyle, phenotype, environmental, social, cultural, and economic factors. Aggressive management of risk factors from diagnosis is necessary to reduce the risk of microvascular and macrovascular complications, focusing on provision of basic treatments (eg, metformin, low-cost statins, and blood pressure-lowering drugs) and other interventions such as smoking cessation. Strengthening of the primary care model of care, better referral linkages, and implementation of rehabilitation services to care for patients with chronic complications will be important. Finally, improvement of physicians' skills, provision of relevant training to non-physician health-care workers, and the development and regular updating of national clinical management guidelines will also be crucial to improve diabetes care in the region.
引用
- Misra A, Sattar N, Tandon N, et al. Clinical management of type 2 diabetes in south Asia. Lancet Diabetes Endocrinol. 2018. PMID: 30287103. doi:10.1016/S2213-8587(18)30199-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。